REATA PHARMACEUTICALS INC's ticker is and the CUSIP is 75615P953. A total of 4 filers reported holding REATA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,130,964 | -76.2% | 20,900 | -78.8% | 0.00% | -75.0% |
| Q1 2023 | $8,964,712 | +130.4% | 98,600 | -3.7% | 0.00% | +100.0% |
| Q4 2022 | $3,890,176 | +26.0% | 102,400 | -16.7% | 0.00% | +100.0% |
| Q3 2022 | $3,088,000 | +470.8% | 122,900 | +590.4% | 0.00% | – |
| Q2 2022 | $541,000 | – | 17,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 60,000 | $5,845,000 | 0.43% |
| BOOTHBAY FUND MANAGEMENT, LLC | 59 | $575,000 | 0.04% |
| GROUP ONE TRADING, L.P. | 3,600 | $351,000 | 0.00% |
| SIMPLEX TRADING, LLC | 60 | $584,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |